Overview

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

Status:
Active, not recruiting
Trial end date:
2023-09-13
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy of different lines of therapies on the TWEAK serum level in patients with non-segmental vitiligo.
Phase:
Phase 4
Details
Lead Sponsor:
Shaimaa Fawzy Abdel-rady Abdel-latif
Treatments:
Latanoprost